Marrone Bio Innovations closes $9.2 million public offering of common stock
Marrone Bio Innovations announced the closing of its previously announced underwritten public offering of registered shares of its common stock for gross proceeds of approximately $9.2 million, which includes the full exercise of the underwriters' over-allotment option. April 29, 2017